UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051577
Receipt number R000058848
Scientific Title An Exploratory Study of New Biomarkers through the Analysis of Liver Repair Mechanisms
Date of disclosure of the study information 2023/08/01
Last modified on 2023/07/11 12:50:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of Rehabilitation Medicine for Muscle Regeneration in Cirrhosis of the Liver An Exploratory Study of New Biomarkers through the Analysis of Liver Repair Mechanisms

Acronym

Rehabilitation Medicine in Liver Cirrhosis

Scientific Title

An Exploratory Study of New Biomarkers through the Analysis of Liver Repair Mechanisms

Scientific Title:Acronym

Exploratory Study of New Biomarkers

Region

Japan


Condition

Condition

Patients with liver cirrhosis

Classification by specialty

Hepato-biliary-pancreatic medicine Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim to examine the effect of exercise therapy on liver fibrosis, regeneration, and improvement of liver function with cirrhosis and comprehensively analyze myokines and extracellular vesicles in the blood during therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To establish a standardized clinical exercise therapy, we will first create a standard muscle attenuation curve over time for patients with cirrhosis based on past clinical data from each institution.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Exercise recommendations at home with a Borg index around ten

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with liver disease of Child A-B and PS0

Key exclusion criteria

Massive ascites, untreated esophageal varices, PS3-4

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shuji
Middle name
Last name Terai

Organization

Graduate School of Medical and Dental Sciences
Niigata University

Division name

Division of Gastroenterology and Hepatology

Zip code

951-8510

Address

Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan

TEL

0252272207

Email

hiroteruk@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name Hiroteru
Middle name
Last name Kamimura

Organization

Graduate School of Medical and Dental Sciences Niigata University

Division name

Division of Gastroenterology and Hepatology

Zip code

9518510

Address

Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan

TEL

0252272207

Homepage URL


Email

hiroteruk@med.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name

hiroteru kamimura


Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japam


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Niigata University School of Medicine

Address

Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan

Tel

0252272625

Email

hiroteruk@med.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 14 Day

Date of IRB

2023 Year 07 Month 04 Day

Anticipated trial start date

2023 Year 07 Month 04 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 07 Month 11 Day

Last modified on

2023 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058848


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name